JULIANNA FERREIRA: Open Payments
NPI 1811512015 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 42 payments from 8 companies in 2025. Trend: 2023 $938 · 2024 $1,034 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $263 |
| ViiV Healthcare Company | 8 | $241 |
| Merck Sharp & Dohme LLC | 7 | $178 |
| Gilead Sciences, Inc. | 6 | $126 |
| Aimmune Therapeutics, Inc. | 2 | $43 |
| Cumberland Pharmaceuticals, Inc. | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
Products named: CABENUVA, PIFELTRO, DOVATO, AVYCAZ, TEFLARO, MAVYRET, ZERBAXA, ZENPEP.
Industry payments across NM — which companies pay providers there.
